Recurrent Childhood Ependymoma Completed Phase 1 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028750 (Recurrent Childhood Ependymoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00101270Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasTreatment